Sunbeam Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.50 M
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -634.10%
- Net Worth -10.53%
- Total Assets -8.03%
About Sunbeam Biotech
Sunbeam Biotech Limited (SBL) is a Public Limited Indian Non-Government Company incorporated in India on 11 March 2008 and has a history of 16 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Balchand Jain, Sunil Chordia, and Rajesh Jain serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01403MH2008PLC177347
- Company No.
177347
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2008
- Date of AGM
31 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Sunbeam Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Chordia  | Director | 20-Apr-2013 | Current |
| Balchand Jain | Director | 04-Jan-2008 | Current |
| Rajesh Jain | Director | 20-Apr-2013 | Current |
Financial Performance of Sunbeam Biotech.
Sunbeam Biotech Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 634.1% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sunbeam Biotech?
In 2017, Sunbeam Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Motisons Jewellers LimitedSunil Chordia is a mutual person
Sunrise Lifespaces LlpBalchand Jain is a mutual person
- Sunrise Skyscrapers Llp
Balchand Jain is a mutual person
- Sunrise Housing Paradise Llp
Balchand Jain and Sunil Chordia are mutual person
- Sunlight Spaces Llp
Balchand Jain is a mutual person
- Sunrise Spaces Private Limited
Balchand Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sunbeam Biotech?
Unlock and access historical data on people associated with Sunbeam Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunbeam Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunbeam Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
